Hims & Hers Health authorizes new $250M share repurchase program; prior $100M fully used

Hims & Hers Health, Inc.

New $250M share repurchase program authorized by Board on Nov 13, 2025, expiring Nov 11, 2028.
From Oct 1 to Nov 7, 2025, repurchased 1,334,572 shares for $55.5M, exhausting prior $100M program.
Repurchases may be made via open market, private negotiations, or Rule 10b5-1 plans; program may be suspended or discontinued.
New authorization increases buyback capacity by 2.5x compared to the prior $100M program.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.